Skip to main content
Log in

Serum Zinc and Copper Levels in Ischemic Cardiomyopathy

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Changes in the copper (Cu) and zinc (Zn) concentrations have been reported previously in ischemic cardiomyopathy (ISCMP). Due to controversial results, the aims of this study were to compare levels of Cu, Zn, and Zn/Cu ratio of ISCMP patients with healthy volunteers and also to investigate the possible relationship between trace elements status in ISCMP patients with the severity of clinical disease based on the New York Heart Association (NYHA) classification. The subjects of this study consisted of 30 ISCMP and 27 healthy volunteers. ISCMP was diagnosed with a history of previous myocardial infarction and also coronary artery disease was confirmed by coronary angiography. Exclusion criteria were renal or hepatic insufficiency, alcohol usage, and intake of supplements containing Cu or Zn within 1 week. Cu and Zn levels have been assayed with atomic absorption spectrophotometry. Statistical analysis was performed with the SPSS 10 software using independent sample t test for comparing the levels of Cu and Zn between ISCMP and normal subjects. The mean Cu level of the ISCMP group (1.54 ± 0.52 mg/L) was significantly more than the Cu levels of the healthy volunteers (1.31 ± 0.24 mg/L; p = 0.048). The mean Zn levels of the ISCMP and healthy volunteers were 1.05 ± 0.28 and 1.12 ± 0.42, respectively, without any significant difference between groups. There was a trend for higher Cu level, lower Zn level, and lower Zn/Cu ratio in NYHA III patients in comparison with NYHA II group. Considering the results of this study, Cu may have a role in the development of ISCMP. Interventions such as administration of Cu chelators to relieve the symptoms or to decrease the progression of ISCMP is needed to be examined in large clinical trials. In this study, the Zn level of ISCMP patients was not significantly different in comparison with the healthy volunteers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Anonymous (1999) Consensus recommendations for the management of chronic heart failure On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure. Am J Cardiol 83(2A):1–38

  2. Massie BM, Shah NB (1997) Evolving trends in the epidemiologic factors of heat failure: rational for preventive strategies and comprehensive disease management. Am Heart J 133:703–712

    Article  PubMed  CAS  Google Scholar 

  3. Zipes DP (2005) Braunwald’s heart disease: a textbook of cardiovascular medicine, 7th edn. Saunders, Philadelphia

    Google Scholar 

  4. Topuzoglu G, Erbay AR, Karul AB, Yensel N (2003) Concentrations of copper, zinc, and magnesium in sera from patients with idiopathic dilated cardiomyopathy. Biol Trace Elem Res 95(1):7–11

    Article  Google Scholar 

  5. Ferrari R, Agnoletti L, Comini L, Gaia G, Bachetti T, Cargnoni A (1998) Oxidative stress during myocardial ischaemia and heart failure. Eur Heart J 19(Suppl B):B2–B11

    PubMed  CAS  Google Scholar 

  6. Bolli R, Marban E (1999) Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79(2):609–634

    PubMed  CAS  Google Scholar 

  7. de Lorgeril M, Salen P, Accominotti M, Cadau M, Steghens JP, Boucher F (2001) Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure. Eur J Heart Fail 3(6):661–669

    Article  PubMed  Google Scholar 

  8. Barandier C, Tanguy S, Pucheu S, Boucher F, De Leiris J (1999) Effect of antioxidant trace elements on the response of cardiac tissue to oxidative stress. Ann N Y Acad Sci 874:138–155

    Article  PubMed  CAS  Google Scholar 

  9. Elsherif L, Ortines RV, Saari JT, Kang YJ (2003) Congestive heart failure in copper-deficient mice. Exp Biol Med (Maywood) 228(7):811–817

    CAS  Google Scholar 

  10. Medeiros DM, Davidson J, Jenkins JE (1993) A unified perspective on copper deficiency and cardiomyopathy. Proc Soc Exp Biol Med 203(3):262–273

    PubMed  CAS  Google Scholar 

  11. Viestenz KE, Klevay LM (1982) A randomized trial of copper therapy in rats with electrocardiographic abnormalities due to copper deficiency. Am J Clin Nutr 35(2):258–266

    PubMed  CAS  Google Scholar 

  12. Malek F, Dvorak J, Jiresova E, Spacek R (2003) Difference of baseline serum copper levels between groups of patients with different one year mortality and morbidity and chronic heart failure. Cent Eur J Public Health 11(4):198–201

    PubMed  CAS  Google Scholar 

  13. Malek F, Spacek R, Polasek R, Karel I (2002) Relation between levels of acute phase proteins and copper and the parameters of systolic and diastolic left ventricular function in patients with chronic heart failure. Cas Lek Cesk 141(14):456–459

    PubMed  CAS  Google Scholar 

  14. Hennig B, Toborek M, Mcclain CJ (1996) Antiatherogenic properties of zinc: implications in endothelial cell metabolism. Nutrition 12(10):711–717

    Article  PubMed  CAS  Google Scholar 

  15. Kosar F, Sahin I, Taskapan C, Kucukbay Z, Gullu H, Taskapan H (2006) Trace element status (Se, Zn, Cu) in heart failure. Anadolu Kardiyol Derg 6(3):216–220

    PubMed  Google Scholar 

  16. Marin J, Rodriguez-Martinez MA (1995) Nitric oxide, oxygen-derived free radicals and vascular endothelium. J Auton Pharmacol 15(4):279–307

    Article  PubMed  CAS  Google Scholar 

  17. Málek F, Spacek R, Polásek R, Karel L, Stanka P, Zenáhlíková M (2001) Serum copper levels in patients with chronic heart failure associated with systolic left ventricular dysfunction and its relation to the severity of cardiac failure. Vnitr Lek 47(11):753–756

    PubMed  Google Scholar 

  18. The Criteria Committee of the New York Heart Association, Inc (1964) Disease of the heart and blood vessels: nomenclature and criteria for diagnosis, 6th edn. Little Brown, Boston

    Google Scholar 

  19. Mehmet EQ (2005) Serum zinc and copper concentrations in rams experimentally infected by Mycoplasma agalactiae. Vet Res 42(1/2):31–36

    Google Scholar 

  20. Atlihan F, Soylemezoglu T, Gokce A, Guvendik G, Satici O (1990) Zinc and copper in congestive heart failure. Turk J Pediatr 32(1):33–38

    PubMed  CAS  Google Scholar 

  21. Cooper GJ, Phillips AR, Choong SY, Leonard BL, Crossman DJ, Brunton DH et al (2004) Regeneration of the heart in diabetes by selective copper chelation. Diabetes 53(9):2501–2508

    Article  PubMed  CAS  Google Scholar 

  22. Białkowska M, Hoser A, Szostak WB, Dybczyński R, Sterliński S, Nowicka G et al (1987) Hair zinc and copper concentration in survivors of myocardial infarction. Ann Nutr Metab 31(5):327–332

    Article  PubMed  Google Scholar 

  23. Ambrosio G, Flaherty JT, Duilio C, Tritto I, Santoro G, Elia PP (1991) Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 87(6):2056–2066

    Article  PubMed  CAS  Google Scholar 

  24. Clayton BE (1980) Clinical chemistry of trace elements. Adv Clin Chem 21:147–176

    Article  PubMed  CAS  Google Scholar 

  25. Ripa S, Ripa R, Giustiniani S (1998) Are failure cardiomyopathies a zinc-deficit related disease? A study on Zn and Cu in patients with chronic failure dilated and hypertrophic cardiomyopathies. Minerva Med 89(11–12):397–403

    PubMed  CAS  Google Scholar 

  26. Zoli A, Altomonte L, Caricchio R, Galossi A, Mirone L, Ruffini MP et al (1998) Serum zinc and copper in active rheumatoid arthritis: correlation with interleukin 1 beta and tumour necrosis factor alpha. Clin Rheumatol 17(5):378–382

    Article  PubMed  CAS  Google Scholar 

  27. DiSilvestro RA, Marten J, Skehan M (1992) Effects of copper supplementation on ceruloplasmin and copper–zinc superoxide dismutase in free-living rheumatoid arthritis patients. J Am Coll Nutr 11(2):177–180

    PubMed  CAS  Google Scholar 

  28. Kucharzewski M, Braziewicz J, Majewska U, Gozdz S (2003) Copper, zinc, and selenium in whole blood and thyroid tissue of people with various thyroid diseases. Biol Trace Elem Res 93(1–3):9–18

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a Grant from the Research Council of the Mazandaran University of Medical Sciences, Iran.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Ghaemian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shokrzadeh, M., Ghaemian, A., Salehifar, E. et al. Serum Zinc and Copper Levels in Ischemic Cardiomyopathy. Biol Trace Elem Res 127, 116–123 (2009). https://doi.org/10.1007/s12011-008-8237-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-008-8237-1

Keywords

Navigation